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Abstract
Understanding the pathogenesis of infectious disease requires the examination and successful integration of parameters
related to both microbial virulence and host responses. As a practical and powerful method to control microbial gene
expression, including in vivo, the tetracycline-regulatable system has recently gained the favor of many investigative groups.
However, some immunomodulatory effects of the tetracyclines, including doxycycline, could potentially limit its use to
evaluate host responses during infection. Here we have used a well-established murine model of disseminated candidiasis,
which is highly dependent on both the virulence displayed by the fungal cells and on the host immune status, to validate
the use of this system. We demonstrate that the pathogenesis of the wild type C. albicans CAF2-1 strain, which does not
contain any tet-regulatable element, is not affected by the presence of doxycycline. Moreover levels of key cytokines,
chemokines and many other biomarkers, as determined by multi-analyte profiling, remain essentially unaltered by the
presence of the antibiotic during infection. Our results indicate that the levels of doxycycline needed to control the
tetracycline regulatable promoter gene expression system have no detectable effect on global host responses during
candidiasis. Because tet-regulatable systems are now being increasingly used in a variety of pathogenic microorganisms,
these observations have wide implications in the field of infectious diseases.
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Introduction
The pathogenesis of infectious disease is complex and results
from a very delicate balance between intrinsic virulence attributes
displayed by the invading microorganism and the host responses
that try to counteract this attack, and it is this interaction which
ultimately determines the outcome of infection [1,2,3]. However,
most reports on this topic are uni-dimensional, either focusing
solely on virulence attributes (‘‘the microbiologist perspective’’) or
host immune responses (‘‘the immunologist perspective’’), but very
rarely on both [4]. With the advent of the molecular era, a variety
of novel tools, mostly gene disruption techniques, have been used
for the identification and characterization of virulence determi-
nants in pathogenic microorganisms, basically following Koch’s
molecular postulates of infectious disease [5]. Most recently, the
tet-regulatable system for control of gene expression [6,7] has been
adapted and used in a variety of microorganisms, including fungi,
parasites and even bacteria [8,9,10,11,12,13]. This system
contains a transactivator and a responsive promoter. The
promoter is active in the absence of tetracycline or one of its
derivatives (most commonly doxycycline is used), and the tet-
regulated genes are transcribed, typically at high levels. Because of
this, the system is normally referred to as ‘‘tet-off’’ system. On the
other hand, transcription from the regulatable promoter is
repressed after the addition of the antibiotic, even at relatively
low levels. A complementary system, (‘‘tet-on’’) functions in an
opposite fashion: it requires the antibiotic to bind to the operator
sequences therefore activating transcription, although in this case
higher concentrations of antibiotic are required [6]. One of the
most appealing features of these systems is the ability to regulate
gene expression in vivo, by simply adding doxycycline (or not) to an
animal’s drinking water, thus allowing the use of these genetically
engineered microbial strains in their corresponding animal models
of infection. Typically, the high specificity and affinity of the
antibiotic allows for the use of doxycycline at low concentrations to
confer tight control of gene expression, particularly in the case of
‘‘tet-off’’ systems [6].
Since the tetracycline regulatable system was developed
specifically as a genetic tool to control/manipulate gene
expression, it is tempting to directly ascribe the differences in
pathogenesis of any such experiments to a ‘‘virulence’’ effect only.
However, most tetracyclines display a number of non-antibiotic
effects, including anti-oxidant, anti-apoptotic, anti-proteolytic,
anti-angiogenic, anti-metastatic, and most importantly, overall
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immunomodulatory and anti-inflammatory effects [14,15,16,17].
Therefore, if manifested, these effects could potentially influence
the outcome of infection and complicate the interpretation of
pathogenesis studies when animals are treated with these
antibiotics [14,18]. Moreover, they may also limit the usefulness
of strains constructed using the tet-regulatable systems for
examining host responses during infection.
Thus, it is important to validate the use of this system for the
study of host immune responses in the pathogenesis of infectious
disease. Here, we sought to demonstrate that doxycyline, under
the standard conditions used to regulate gene expression in vivo
does not display significant effects on global host responses during
the infectious process. To this end we have used a well established
murine model of hematogenously disseminated candidiasis, since,
as an opportunistic pathogen, the fungus Candida albicans is one of
the microorganisms in which this balance between virulence and
host responses is best exemplified.
Materials and Methods
All animal experimentation was conducted following the
National Institutes of Health guidelines for housing and care of
laboratory animals and performed in accordance with Institutional
regulations after pertinent review and approval by the Institutional
Animal Care and Use Committee at The University of Texas at
San Antonio (Institutional Welfare Assurance number A3592-01,
IACUC protocol number MU018).
Strain and media
C. albicans CAF2-1 strain [19] was used for these studies. This is
a URA3/ura3 heterozygous strain derived from the SC5314 used
in the genome sequencing project. The fully virulent CAF2-1
strain is frequently used as a wild-type control for virulence studies,
particularly in the characterization of isogenic mutant strains
constructed using the URA blaster technique [19].
Animal experiments
Cultures of C. albicans CAF2-1 strain for injection were grown
overnight at 25uC in yeast extract-peptone-dextrose (YPD)
medium without doxycycline. Cells were harvested by centrifuga-
tion and washed. After counting, appropriate dilutions were made
and cells (in a final volume of 200 ml) were injected into the lateral
tail veins of 6–8 week old female BALB/c mice. Five mice were
used for each of the four experimental groups, which were as
follows: two of these groups were given drinking water containing
5% sucrose and 2 mg/ml doxycycline starting three days prior to
infection (this is the antibiotic concentration and regimen regularly
used to control gene expression when using tet-regulatable strains,
[12,20]), whereas the other two groups of animals were given
drinking water with sucrose (5%) only; for each condition (addition
or omission of antibiotic) one group of animals was infected with
the C. albicans CAF2-1 strain via tail vein and the other group was
not inoculated (served as uninfected controls). The infection
experiments were also repeated using a different infecting
inoculum for survival assessment. Another four parallel groups
(same conditions as above regarding infection and antibiotic
treatment) of mice were included for a time-scheduled sacrifice at
3 days post-infection. In these animals the brain, spleen, and
kidneys were removed for the determination of fungal burden, as
well as for analyses of host responses (see below). One kidney from
each animal was put aside for histological analysis; these were fixed
in 10% buffered formalin, embedded in paraffin, and thin tissue
slices were removed and stained with Grocott-Gomori methena-
mine-silver (GMS) for fungal elements and with hematoxylin-eosin
(HE) staining for tissue pathology. Fungal organ burdens were
determined from the remaining samples by weighing and
homogenizing the tissues (as below) and then plating aliquots
onto solid YPD media to determine viable colony forming units
(CFU).
Analyses of host responses
All analyses of host responses were performed using organs and
serum samples recovered at time-scheduled sacrifices three days
post-infection (or at the exact same time for matched uninfected
animals). After necropsy, 300 ml PBS with complete protease
inhibitor cocktail (Roche Diagnostics GmbH, Germany) were used
for homogenization of tissues (kidney and spleen), and centrifuged
at 12,000 rpm for 5 min at 4uC. The sample supernatants were
collected and stored at 280uC until further analyses. Blood was
obtained via cardiac puncture, placed in serum separator tubes,
centrifuged and serum was stored at 280uC until analyzed. For
individual sample analysis of each mouse from each group, Multi-
plex cytokine and chemokine array analysis was performed using
the Bio-Plex ProTM protein multi-array system (BIO-RAD Lab,
Inc. Hercules, Calif.); a mouse 23-plex assay was used according to
the recommendations of the manufacturer. Proteins assayed
included interleukin-1a (IL-1a), IL-1b, IL-2, IL-3, IL-4, IL-5,
IL-6, IL-9, IL-10, IL-12 (p40), IL-12 (p70), IL-13, IL-17, eotaxin,
granulocyte colony stimulating factor (G-CSF), granulocyte
monocyte colony stimulating factor (GM-CSF), interferon-c
(IFN-c), KC (keratinocyte-derived chemokine, a potent neutrophil
chemoattractant which is the functional mouse homolog of human
IL-8), monocyte chemotactic protein 1 (MCP-1), macrophage
inflammatory protein-1a (MIP-1a), MIP-1b, RANTES and tumor
necrosis factor-a (TNF-a).
In addition, pooled samples from each group of mice containing
equal amounts of tissue homogenates (from kidney and spleen) or
serum from each animal in the same experimental group were
submitted to Rules Based Medicine for multianalyte profiling
using the LuminexH-based Multi-Analyte Profile (MAP) technol-
ogy platform (Rules Based Medicine, Austin, Texas). Analytes
measured included apolipoprotein (Apo) A1, CD40, CD40 ligand,
C-reactive protein (CRP), epidermal growth factor, endothelin-1,
eotaxin, factor VII, fibroblast growth factor (FGF)–9, FGF-basic,
fibrinogen, granulocyte chemotactic protein–2, granulocyte mac-
rophage-colony–stimulating factor, glutathione S-transferase a,
haptoglobin, interferon-gamma, immunoglobulin A (IgA), IL-1,
IL-11, IL-12p70, IL-17, IL-18, IL-1a, IL-1b, IL-2, IL-3, IL-4, IL-
5, IL-6, IL-7, 10-kDa interferon-gamma-inducible protein (IP-10),
the neutrophil chemoattractant KC/GRO alpha, leukemia
inhibitory factor (LIF), lymphotactin, MCP-1, MCP-3, MCP-5,
macrophage-colony-stimulating factor, macrophage-derived che-
mokine, MIP–1a, MIP-1b, MIP-1c, MIP-2, MIP-3b, matrix
metalloproteinase–9 (MMP-9), myeloperoxidase (MPO), myoglo-
bin, oncostatin M, RANTES, serum amyloid P-component (SAP),
stem cell factor, serum glutamic-oxaloacetic transaminase
(SGOT), tissue inhibitor of metalloproteinase type-1 (TIMP-1),
tissue factor, tumor necrosis factor alpha (TNF-a), thrombopoietin
(TPO), vascular cell adhesion molecule 1 (VCAM-1), vascular
endothelial cell growth factor (VEGF), and von Willebrand factor
(vWF). Analyses were performed in a Luminex 100 instrument
(Luminex, Austin, Texas).
Statistical analysis
Survival data and differences between groups were analyzed
using the Kaplan-Meier logrank test. The Mann-Whitney test was
used to determine statistical significance for differences in CFU
data. A Student’s t-test was used to compare levels of cytokines and
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chemokines between the corresponding samples from doxycycline
treated and untreated groups of animals. P,0.05 was considered
statistically significant. Analyses were performed using Prism by
GraphPad Prism (GraphPad Software Inc., San Diego, CA).
Results
The course of hematogenously disseminated candidiasis
after infection with a wild type Candida albicans strain is
not affected by the presence of doxycycyline
For all experiments we used the C. albicans CAF2-1 strain in the
murine model of hematogenosuly disseminated candidiasis in
which, both virulence attributes and host immune responses play
important roles. This strain is well characterized as it serves as the
wild type parental strain for the construction of a majority of C.
albicans deletion mutant strains [19]. As such, the CAF2-1 strain
does not contain any tetracycline regulatable element. Thus, in
this strain presence or absence of doxycycline does not regulate
gene expression, and should not affect the intrinsic virulence of this
strain. It follows that any differences on the overall pathogenicity
observed in the presence of the antibiotic using this animal model
should be strictly due to an effect on host responses. As seen in
Figure 1, by all assessment methods including survival, fungal
organ burden and histology, the pathogenicity of the C. albicans
CAF2-1 strain in this animal model was unaltered by the presence
of doxycycline. Two different infecting inocula were tested to
monitor the differences in mice survival, and in both cases the
corresponding survival curves for doxycycline-treated (2 mg/ml in
drinking water containing 5% sucrose) and untreated animals were
almost identical (Fig 1A), with no statistically significant differences
detected between the groups. The same was true for fungal
burden, as organ loads in kidney, spleen and brain were similar,
irrespective of antibiotic treatment (Figure 1B). As expected, the
morphology of fungal cells in infected tissues was also unaffected
by the presence of doxycycline (Fig 1C). Perhaps most important
from the point of view of host responses, histopathological findings
were virtually identical for both groups of animals (treated and
untreated), as shown in Fig 1D. Overall, these results demonstrate
a lack of effect of the antibiotic on virulence mechanisms (as
anticipated) and, most importantly for the purpose of the current
study, also point to a lack of antibiotic effect on the overall
pathogenesis of candidiasis.
Lack of effect of doxycycline on host responses during
disseminated candidiasis
The previous set of experiments indicated a lack of an effect of
doxycycline on the overall course of infection and pathogenesis of
hematogenously disseminated candidiasis in mice. However, it is
important to corroborate these observations by determining the
levels of specific chemokines, cytokines and other markers of
infection and host response in samples obtained from animals with
and without the antibiotic in their water. A first level of analysis
was performed using individual samples (organ homogenates and
serum samples) obtained from every mouse in each group using
the Bio-Plex Mouse Cytokine 23-Plex. We first demonstrated that,
in the absence of infection, doxycycline does not alter basal levels
of expression of these analytes (see Figure S1). Also, as shown in
Figure 2, levels of cytokines, chemokines and growth factors in
kidney and spleen homogenates, as well as in serum samples after
infection with the C. albicans CAF2-1 strain, were virtually
indistinguishable between doxycyline-treated and untreated
groups of mice.
A more comprehensive analysis of the global host response in
the different groups of mice was performed by multianalyte
profiling using the Rules Based Medicine’s mouse MAP, that
allows for the concomitant examination of an extended panel of
broad spectrum biomarkers relevant to infection (a total of 59
analytes, including cytokines, chemokines, growth factors, acute-
phase reactants and other metabolites). Figure 3 shows the results
of multianalyte profiling analyses for kidney samples (the kidney is
the main target of infection) obtained from doxycycline-treated
mice 3 days after infection with C. albicans CAF2-1 strain,
compared to animals infected in the absence of the antibiotic.
This direct comparison revealed no major differences in levels of
the multiple analytes between doxycycline-treated versus untreat-
ed mice, thus corroborating that the antibiotic has a minimal (if
any) effect on host responses under the conditions used. Similar
results were obtained in a comparison between the doxycycline-
treated and untreated uninfected animals, further demonstrating
that basal levels of these biomarkers in the absence of infection are
unaffected by doxycycline treatment (see Figure S2). The absolute
values for the different analytes in each group of mice are provided
in Table S1. Results from similar analyses for spleen homogenates
and serum samples also indicated a global lack of effect of
antibiotic treatment on systemic host responses, both with and
without infection (data not shown).
Discussion
In order to validate the tet-regulatable system we have used a
murine model of hematogenously disseminated candidiasis. C.
albicans is a formidable opportunistic human pathogen: in
compromised hosts this fungus can cause disease, ranging from
superficial to life-threatening invasive candidiasis [21]. In fact,
mostly due to the progress of modern medicine and an expanding
population of severely immunodepressed patients, disseminated
candidiasis now represents the third to fourth most common
nosocomial infection worldwide with, most importantly, unac-
ceptably high morbidity and mortality rates [22,23,24,25]. In this
animal model of infection, both virulence attributes and host
immune responses play important roles [26,27,28,29,30], which
makes this model an ideal one for the specific purpose of this
study. The infection reasonably mimics the progression of disease
observed in humans, and faithfully recapitulates the main events
associated with systemic disease; including circulation of cells
through the vasculature, extravasation, dissemination to distal
sites, establishment of deep seated infection, and sepsis [31,
32,33].
For the direct assessment of specific virulence attributes in C.
albicans, most studies have used the URA blaster [19] or similar
gene disruption techniques to generate knock-out mutant strains
and directly compare the virulence of the corresponding gene
deletion strains versus that of the parental strain. More recently,
the conditional tetracycline-regulatable promoter system to control
gene expression was adapted for Candida and used to explore
several aspects of C. albicans pathogenicity [12,20,34,35]. In the
‘‘tet-off’’ system, a tetracycline-controlled transactivator interacts
with a responsive promoter to regulate expression of the gene of
interest. Expression is controlled from outside by a tetracycline,
most commonly doxycycline. The antibiotic is widely considered
safe and nontoxic at the relatively low doses required for gene
inactivation [6,36]. However, some immunomodulatory effects of
the tetracyclines could potentially limit its use to evaluate host
responses during infection [14,15,16,17]. Thus, we performed a
series of experiments to validate the use of this system in the
analyses of host responses during the pathogenesis of candidiasis.
We demonstrate that, in stark contrast with results observed with
genetically engineered tet-regulatable strains that display clearly
Tet-Regulatable System for Microbial Pathogenesis
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Figure 1. Doxycycline does not affect the course of hematogenously disseminated candidiasis in mice infected with the C. albicans
CAF2-1 strain. Panel A, Survival curves for groups of mice infected with the C. albicans CAF2-1 strain in both the presence (red) or absence (blue) of
doxycycline at two different infecting inocula. No statistically significant differences were detected between doxycycline-treated and untreated animals.
Panel B, Organ fungal burdens at time of sacrifice (three days post-infection) for two different groups of mice challenged with 56105 cells of C. albicans
CAF2-1 strain in the presence (red) or absence (blue) of doxycycline. Results are expressed as geometric means and standard deviations for log CFU/g
values. For all organs analyzed, no statistically significant differences were detected between doxycycline-treated and untreated mice.
Panel C, Morphology of C. albicans CAF2-1 cells present in kidneys retrieved from doxycycline-treated and untreated mice as revealed by GMS staining.
The morphology of fungal elements in tissues, mostly filamentous, was indistinguishable regardless of antibiotic treatment. Magnification is x100.
Panel D, Histopathological analysis of kidneys retrieved frommice after infection with C. albicans strain CAF2-1 strain in the presence or absence of doxycyc-
line as revealed by H & E staining, displaying small, mostly cortical lesions irrespective of antibiotic treatment. Magnification is x40. DOX: doxycycline.
doi:10.1371/journal.pone.0020449.g001
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demonstrable effects on virulence [20,34,35,37], the course of
infection and overall pathogenesis of the wild type C. albicans
CAF2-1 strain is not affected by the presence or absence of
doxycycline. Moreover levels of key cytokines, chemokines and
many other biomarkers, as determined by multi-analyte profiling,
remain essentially unaffected by the presence or absence of the
antibiotic during infection, clearly indicating that doxycycline,
under these conditions, does not affect host responses during the
infectious process.
Taken together, our results demonstrate that doxycycline, at the
standard concentrations used to regulate gene expression in the
tet-off system, does not alter host responses during infection. Of
course, these results should be approached with caution and may
not be applicable to mucosal models of infection, where the
Figure 2. Doxycycline does not affect host immune responses during systemic candidiasis. Determination of cytokine and chemokine
levels, using the Bio-Plex Pro protein multi-array system, in kidney (panel A), spleen (panel B) and serum samples (panel C) in groups of mice (n = 5 per
group) three days after challenge with C. albicans strain CAF2-1, in the absence (blue bars) or presence (red bars) of doxycycline in the animals’
drinking water. Results are presented as averages and standard deviations. No statistically significant differences were detected between doxycycline-
treated and untreated animals for any of the chemokines and cytokines analyzed.
doi:10.1371/journal.pone.0020449.g002
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tetracyclines’ antibiotic effect may impact the normal bacterial
microbiota; it may be possible to overcome this limitation,
however, by using chemically modified tetracyclines and tetracy-
cline analogues which lack antibacterial activity [38]. We also note
that our observations may not necessarily extend to the so called
‘‘tet-on’’ system, which generally requires a higher concentration
of antibiotic to activate gene expression [6,39]. Added to the well
characterized safety, pharmacodynamic, pharmacokinetic and
favorable toxicological properties of these antibiotics [6,36], these
results further validate the utility of microbial strains constructed
using the tet-regulatable gene expression system in pathogenesis
studies and for the analyses of host responses during infection. Our
results provide reassurance that under the standard conditions of
doxycycline use, any observed difference in pathogenesis is
overwhelmingly due to the antibiotic’s control of gene expression
(i.e. effect on virulence of the pathogen) and not due to any
immunoregulatory effects exerted by the drug. Because of the
increased popularity of tet-regulatable systems to control gene
expression in a variety of pathogenic microorganisms, including
parasites, fungi and bacteria [8,9,10,13,20,34], and the use of
these genetically engineered strains in the corresponding animal
models of infection, our observations have broad applicability in
the fields of Microbiology and Infectious Diseases. Moreover, they
transcend these fields since tet-regulatable gene expression
techniques are also being increasingly used in mamalian systems,
including transgenic animal models and gene therapy applications
in humans [40,41].
Supporting Information
Figure S1 Determination of cytokine and chemokine
basal levels, using the Bio-Plex Pro protein multi-array
system, in kidney (panel A), spleen (panel B) and serum
samples (panel C) from uninfected groups of mice (n=5
per group) in the absence (blue bars) or presence (red
bars) of doxycycline in their drinking water. Results are
averages and standard deviations. No statistically significant
differences were detected between doxycycline-treated and
untreated animals for any of the chemokines and cytokines
analyzed.
(PDF)
Figure S2 Multiplex analysis using the mouse multi-
analyte profiling (MAP, Rules-Based Medicine) of pooled
kidney tissue homogenates obtained from a group of
doxycycline-treated mice (n=5) in the absence of
infection as compared to doxycycline-untreated ani-
mals. Comparative values are expressed as Ratio vs Control
(uninfected and in the absence of doxycycline, sacrificed at the
very same time), which is arbitrarily assigned a value of 1 for each
analyte and indicated by the solid grid line along the y axis. The
dotted grid lines along the y axis indicate ratios of 0.5 and 2; any
analyte for which the corresponding value was below or above this
range was arbitrarily considered differentially expressed.
(PDF)
Table S1 Absolute values for concentrations of the
different analytes determined at time of sacrifice in
pooled (n=5) kidney homogenates from the different
groups of mice (infected and uninfected, in the absence
or presence of doxycycline-DOX), using Rules Based
Medicine’s Rodent MAP.
(PDF)
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